FDA-approved GLP-1 medications — semaglutide and tirzepatide — prescribed and monitored by a board-certified physician. Average 15% body weight reduction at 6 months.
Prescription medications issued only after physician review. Individual results vary. Not appropriate for all patients. FDA-approved and compounded options available.
GLP-1 receptor agonists like semaglutide and tirzepatide produce meaningful, sustained weight loss in clinical trials. Your results are physician-guided and adjusted over time.
GLP-1 receptor agonists work by mimicking the GLP-1 hormone — reducing appetite, slowing gastric emptying, and improving insulin sensitivity. Your physician reviews your full health history to determine the most appropriate medication and starting dose.